NCT05514769 2026-03-31
Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer
Nanchong Central Hospital
Phase NA Recruiting
Clinical Trials
18 trialsNCT06464978 2026-03-31
Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy
Nanchong Central Hospital
Phase NA Recruiting
NCT07482566 2026-03-20
SIEWERT-RCT
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Phase NA Recruiting
NCT07441785 2026-03-02
PROXISTAT
P. Herzen Moscow Oncology Research Institute
Recruiting
NCT07334431 2026-01-12
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT06313801 2025-11-21
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
Nizhny Novgorod Regional Clinical Oncology Center
Phase 2 Recruiting
NCT04780256 2025-10-03
Endoscopic Resection of Gastrointestinal Neoplasms
Azienda USL Reggio Emilia - IRCCS
Recruiting
NCT07142122 2025-08-26
TLPG-CBVP
Fujian Cancer Hospital
Phase NA Recruiting
NCT06105515 2025-07-22
LE-RACUS
Region Stockholm
Phase NA Recruiting
NCT06793917 2025-07-20
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Fujian Cancer Hospital
Phase 3 Recruiting
NCT03093688 2025-07-02
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Recruiting
NCT05319639 2025-02-27
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
Fujian Cancer Hospital
Phase 1/2 Recruiting
NCT04214990 2024-12-27
EASTERN
National Cancer Center, Korea
Phase 3 Recruiting
NCT04890171 2024-12-27
ERASE-GC
National Cancer Center, Korea
Phase NA Recruiting
NCT06035250 2023-09-28
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Chinese Academy of Sciences
Recruiting
NCT04519151 2023-06-08
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
Phase 2 Recruiting
NCT05722275 2023-02-14
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Chinese Academy of Sciences
Recruiting
NCT04740346 2021-10-27
Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)
National Cancer Center, Korea
Phase NA Recruiting